Source link : https://newshealth.biz/health-news/ema-rejects-alzheimers-drug-after-trial-falls-short/
Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a positive benefit-risk balance. Medscape News Europe Source link : https://www.medscape.com/viewarticle/ema-rejects-alzheimers-drug-after-trial-falls-short-2025a1000yz0?src=rss Author : Publish date : 2025-12-12 17:12:00 Copyright for syndicated content belongs to the linked Source.
The post EMA Rejects Alzheimer’s Drug After Trial Falls Short first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-12 17:12:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8